Nathan Slaughter
Scarcity & Wealth
John Reese
Validea
Roger Conrad
The Utility Forecaster
Paul Tracy
Top 10 Stocks

Nucor (NUE): Turnaround in steel?


Bookmark and Share

By Sy Harding, editor The Long and Short Stock Advisor

 Nucor Corp. (NYSE: NUE) is a is a potential turnaround play. The manufactures steel and steel products, is in fact the largest such producer in the U.S. based on revenues.

It has suffered from the recession as manufacturing and construction has plummeted. From earnings per share of $4.98 in 2007, and $6.01 in 2008, Nucor swung all the way to a loss of $1.13 a share in the first nine months of this year on a big 58% plunge in revenues.

With the economy recovering and Washington embarked on efforts to produce jobs, which includes focusing on road and bridge upgrades and expansion, the steel industry is probably due to pull out of its down cycle.

Advertisement
Banner

Meanwhile, the industry-wide slump in demand has run U.S. steel inventories to a historically low level according to the Metals Service Center Institute.

Nucor has been successful in cutting its costs enough that quarterly losses were at their worst in the first quarter of the year, at $.60 a share, and have been less with each subsequent quarter, the company losing only $.10 a share in its September quarter.

The company recently said it expects to break the pattern of three quarterly losses with a 'breakeven to slightly positive' performance this quarter.

Meanwhile, research firm Value Line is forecasting a return to slight profitability in the current quarter, $3 a share for the full year next year, and a return to aggressive long-term growth and earnings of $8 a share in the 2012-2014 period.

Nucor has a history of building steel mills inexpensively and operating them very efficiently with a well-paid but mostly non-union work force.

The company has a very strong balance sheet, with a high level of cash, which has allowed its success with acquisitions to continue, as it also continues to take market share away from less efficient competitors.

On the technical analysis side, Nucor is rising off a trendline of support at the bottom of a rising trading band. It has just broken out above its 20-week moving average. MACD, which has provided quite timely buy and sell signals in the past, has triggered a new buy signal.

And the stock‟s Internal Strength Index is rising and still has quite a ways to go if it is headed for its overbought zone.

We believe Nucor is a worthwhile turnaround play, provided the economy continues to recover. We have an upside target of 60, and suggest a mental protective stop at 38.50.

Learn more about this investment newsletter at The Long and Short Stock Advisor.


Banner
News Flash

Stock up on staples
by Joon Choi, contributing editor Systems & Forecasts

History shows the stock market, on average, loses money during the June through October period.  The question is where one should aim to invest to profit during this unfavorable season. 


Read more...

 

Bond funds for bear protection
by Mark Salzinger, editor The No-Load Fund Investor

What funds offer bear market protection? We currently include several intermediate-term, medium-quality U.S. bond funds in our Best Buys list.


Read more...


   

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...

 

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary